{"id":"NCT02954458","sponsor":"Shire","briefTitle":"Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS)","officialTitle":"A Prospective, Open-label, Long-term Safety and Efficacy Study of Teduglutide in Pediatric Patients With Short Bowel Syndrome Who Completed TED-C14-006 or SHP633-301","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-01-09","primaryCompletion":"2020-11-05","completion":"2020-11-05","firstPosted":"2016-11-03","resultsPosted":"2021-10-13","lastUpdate":"2025-03-28"},"enrollment":61,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Short Bowel Syndrome"],"interventions":[{"type":"DRUG","name":"TED","otherNames":[]},{"type":"OTHER","name":"SOC","otherNames":[]},{"type":"DEVICE","name":"Syringe","otherNames":[]},{"type":"DEVICE","name":"Needle","otherNames":[]}],"arms":[{"label":"Standard of care (SOC) treatment +/- teduglutide (TED)","type":"EXPERIMENTAL"}],"summary":"This study will follow participants who completed the TED-C14-006 study. The purpose of this study is to evaluate the long-term safety and efficacy of teduglutide in pediatric participants with Short Bowel Syndrome (SBS). This study will also offer teduglutide treatment to eligible participants, regardless of treatment received in TED-C14-006 or SHP633-301.","primaryOutcome":{"measure":"Number of Participants With Treatment-emergent Adverse Events (TEAEs)","timeFrame":"From start of study drug administration up to follow-up (up to 46 months)","effectByArm":[{"arm":"Non-teduglutide/Non-teduglutide Treatment (NTT/NTT)","deltaMin":6,"sd":null},{"arm":"Non-teduglutide/Teduglutide Treatment (NTT/TED)","deltaMin":3,"sd":null},{"arm":"Teduglutide /Non-teduglutide Treatment (TED/NTT)","deltaMin":1,"sd":null},{"arm":"Teduglutide/Teduglutide Treatment (TED/TED)","deltaMin":50,"sd":null}],"pValues":[]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":22,"countries":["United States","Belgium","Canada","Finland","Italy","United Kingdom"]},"refs":{"pmids":[],"seeAlso":["https://clinicaltrials.takeda.com/study-detail/5f6b5fd94db2bf003ab470c2"]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":7},"commonTop":["Vomiting","Pyrexia","Upper respiratory tract infection","Cough","Abdominal pain"]}}